K913864 is an FDA 510(k) clearance for the PCP DIRECT RIA KIT (I-125). Classified as Radioimmunoassay, Phencyclidine (product code LCL).
Submitted by Immunalysis Corporation (Glendale, US). The FDA issued a Cleared decision on October 11, 1991 after a review of 45 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Immunalysis Corporation devices